| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
The UKK Institute for Health Promotion and Research (M.F., K.K.-H., A.N.), Tampere; and the Departments of Clinical Nutrition (R.V., V.H., M.U.) and Medicine (M.L.), University of Kuopio, Kuopio, Finland
Address all correspondence and requests for reprints to: Dr. Mikael Fogelholm, The UKK Institute, POB 30, 33501 Tampere, Finland. E-mail: mikael.fogelholm{at}helsinki.fi
This study examined whether the Trp64Arg mutation in the
ß3-adrenergic receptor (ß3AR) and the A
G
mutation in the uncoupling protein-1 (UCP-1) genes have associations
with weight loss and subsequent weight maintenance. Seventy-seven obese
(body mass index range, 2946 kg/m2), clinically healthy,
premenopausal women were studied. A 12-wk weight reduction by very low
calorie diet (VLCD) was followed by a 40-wk weight maintenance phase.
The subjects were divided into four groups according to their
ß3AR and UCP-1 genotype: no mutation (control; n =
37), only Trp64Arg mutation in the ß3AR gene
(n = 12), only A
G mutation in the UCP-1 gene (n = 23), and
both mutations (n = 5). Subjects with both mutations had a lower
weight reduction during VLCD than the controls [-10.5 ± 0.6
(±SEM) vs. -14.0 ± 0.5 kg;
P = 0.051, by ANOVA]. During the maintenance
phase, weight in subjects with both mutations increased by 5.8 ±
1.5 kg, but remained unchanged in the controls (-0.5 ± 0.8 kg;
P = 0.041). The changes in weight in subjects with
only one of the mutation were close to the results in the controls.
Resting energy expenditure, adjusted for fat mass, fat-free mass, and
maximal aerobic power, did not change differently between the groups
throughout the study. The results suggest that a combination of the
Trp64Arg mutation in the ß3AR and the A
G
mutation in the UCP-1 genes may be associated with faster weight gain
after a VLCD.
This article has been cited by other articles:
![]() |
J. Klein, S. Westphal, D. Kraus, B. Meier, N. Perwitz, V. Ott, M. Fasshauer, and H H. Klein Metformin inhibits leptin secretion via a mitogen-activated protein kinase signalling pathway in brown adipocytes J. Endocrinol., November 1, 2004; 183(2): 299 - 307. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Martinez, M. S. Corbalan, A. Sanchez-Villegas, L. Forga, A. Marti, and M. A. Martinez-Gonzalez Obesity Risk Is Associated with Carbohydrate Intake in Women Carrying the Gln27Glu {beta}2-Adrenoceptor Polymorphism J. Nutr., August 1, 2003; 133(8): 2549 - 2554. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. J. Dionne, A. N. Turner, A. Tchernof, T. I. Pollin, D. Avrithi, D. Gray, A. R. Shuldiner, and E. T. Poehlman Identification of an Interactive Effect of {beta}3- and {alpha}2b-Adrenoceptor Gene Polymorphisms on Fat Mass in Caucasian Women Diabetes, January 1, 2001; 50(1): 91 - 95. [Abstract] [Full Text] |
||||
![]() |
S. A. Urhammer, T. Hansen, K. Borch-Johnsen, and O. Pedersen Studies of the Synergistic Effect of the Trp/Arg64 Polymorphism of the {beta}3-Adrenergic Receptor Gene and the -3826 A->G Variant of the Uncoupling Protein-1 Gene on Features of Obesity and Insulin Resistance in a Population-Based Sample of 379 Young Danish Subjects J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 3151 - 3154. [Abstract] [Full Text] |
||||
![]() |
J. Klein, M. Fasshauer, M. Benito, and C. R. Kahn Insulin and the {beta}3-Adrenoceptor Differentially Regulate Uncoupling Protein-1 Expression Mol. Endocrinol., June 1, 2000; 14(6): 764 - 773. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |